A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Al-Abdullah, Ismail, Ph.D. Bookmark and Share

Ismail Al-Abdullah, Ph.D. Research

Coating Human Islets with Macromolecular Heparin
This project is carried out in collaboration with University of Uppsala Sweden.  Achieving successful reversal of diabetes with minimum Heparin precoated islet mass would have a major impact in translating the result generated from this study to clinical practice to use islet isolated from a single donor to reverse a single type 1 diabetic recipient.
 
Growth Factors in Culture Media Supplement to Improve Islet Quality and Quantity
This proposal will test the hypothesis that culturing islets in serum free medium supplemented with growth factors such as gastrin, EGF and exendin can promote islet function, yields; promote proliferation of islet progenitor cells to ultimate transplantation of islets from a single donor.

The Role of alpha-glutathione S-transferase (α-GST) in Human Islets
The ultimate goal of this study is to develop a simple, fast and reliable biomarker to monitor islet function and survival. Based on our feasibility study that islets are indeed contain and secrete α-GST. This novel biomarker will be used to monitor islet function during the isolation and post culture. We intend to use this biomarker to monitor islet integrity and develop the best conditions for islet recovery and survival post transplant.
 
Collaboration with the University of Uppsala
Our main focus on this collaboration is to further improve our islet isolation procedure for enhancing and improving islet quality so that a single diabetic patient could be transplanted and reverse diabetes with islets isolated from a single donor.
 
Collaboration on Non-Human Primate Islet Transplantation Protocol
We have initiated this collaboration with Dr. Defu Zeng and University of Maryland for induction of tolerance in the recipients. Donor pancreas from non-human primate was shipped and the isolated islets when transplanted into diabetic mice, diabetes were reversed.  The outcome of this study results obtain from this study will have major impact for FDA approval for eventual application of novel strategies for tolerance induction to cure type 1 diabetic patients with islets isolated from cadaveric donors.
 
Development of Novel Peptide for Collagenase and Neutral Protease Activities
Collaboration with Dr. Markus Kalkum from the immunology department at City of Hope has been established and we have already developed a novel peptide for collagenase and neutral protease activities assessment to define a better enzymes for pancreas digestion to free the islets for ultimate goal to transplant islets into a single diabetic recipient isolated from a single cadaveric donor pancreas.
 

Ismail Al-Abdullah, Ph.D. Lab Members

Ismail Al-Abdullah, Ph.D.
Research Professor
626-246-HOPE (4673) ext. 60109
 
Luis Valiente
Senior Research Associate
626-246-HOPE (4673) ext. 65639
 
Shiela Bilbao
Research Associate II
626-246-HOPE (4673) ext. 61410
 
Alina Oancea, M.D.
Research Associate II
626-246-HOPE (4673) ext. 63923
 
Brian McFadden
626-246-HOPE (4673) ext. 33101
Research Associate I
 

Al-Abdullah, Ismail, Ph.D.

Ismail Al-Abdullah, Ph.D. Research

Coating Human Islets with Macromolecular Heparin
This project is carried out in collaboration with University of Uppsala Sweden.  Achieving successful reversal of diabetes with minimum Heparin precoated islet mass would have a major impact in translating the result generated from this study to clinical practice to use islet isolated from a single donor to reverse a single type 1 diabetic recipient.
 
Growth Factors in Culture Media Supplement to Improve Islet Quality and Quantity
This proposal will test the hypothesis that culturing islets in serum free medium supplemented with growth factors such as gastrin, EGF and exendin can promote islet function, yields; promote proliferation of islet progenitor cells to ultimate transplantation of islets from a single donor.

The Role of alpha-glutathione S-transferase (α-GST) in Human Islets
The ultimate goal of this study is to develop a simple, fast and reliable biomarker to monitor islet function and survival. Based on our feasibility study that islets are indeed contain and secrete α-GST. This novel biomarker will be used to monitor islet function during the isolation and post culture. We intend to use this biomarker to monitor islet integrity and develop the best conditions for islet recovery and survival post transplant.
 
Collaboration with the University of Uppsala
Our main focus on this collaboration is to further improve our islet isolation procedure for enhancing and improving islet quality so that a single diabetic patient could be transplanted and reverse diabetes with islets isolated from a single donor.
 
Collaboration on Non-Human Primate Islet Transplantation Protocol
We have initiated this collaboration with Dr. Defu Zeng and University of Maryland for induction of tolerance in the recipients. Donor pancreas from non-human primate was shipped and the isolated islets when transplanted into diabetic mice, diabetes were reversed.  The outcome of this study results obtain from this study will have major impact for FDA approval for eventual application of novel strategies for tolerance induction to cure type 1 diabetic patients with islets isolated from cadaveric donors.
 
Development of Novel Peptide for Collagenase and Neutral Protease Activities
Collaboration with Dr. Markus Kalkum from the immunology department at City of Hope has been established and we have already developed a novel peptide for collagenase and neutral protease activities assessment to define a better enzymes for pancreas digestion to free the islets for ultimate goal to transplant islets into a single diabetic recipient isolated from a single cadaveric donor pancreas.
 

Lab Members

Ismail Al-Abdullah, Ph.D. Lab Members

Ismail Al-Abdullah, Ph.D.
Research Professor
626-246-HOPE (4673) ext. 60109
 
Luis Valiente
Senior Research Associate
626-246-HOPE (4673) ext. 65639
 
Shiela Bilbao
Research Associate II
626-246-HOPE (4673) ext. 61410
 
Alina Oancea, M.D.
Research Associate II
626-246-HOPE (4673) ext. 63923
 
Brian McFadden
626-246-HOPE (4673) ext. 33101
Research Associate I
 
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
 
Hours: M – F, 8 a.m. to 5 p.m. (PST)
 
Calls received after 5 p.m. will be returned the next business day.
Patient Care Overview

Info for Referring Physicians
City of hope welcomes patient referrals from physicians throughout the world. City of Hope is located near northeast Los Angeles, in Duarte, California.



NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...